Walleye Trading’s Evoke Pharma EVOK Stock Holding History

Walleye Trading’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10	Closed	-$5K	–	5449
2015 Q4	$5K	Buy	+10	New	+$5.08K	﹤0.01%	4923

Other funds holding EVOK

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Walleye Trading's EVOK Position: Q1 2016 in Review

Walleye Trading sold out of Evoke Pharma (EVOK) in Q1 2016, closing a stake of 10 shares — an estimated $5K sold.

Walleye Trading first reported a position in EVOK in Q4 2015 and held it in 1 quarter. The position peaked at $5K in Q4 2015. 11 funds tracked by Wall St. Rank hold EVOK as of Q1 2016.

Walleye Trading reported no remaining Evoke Pharma position as of Q1 2016 after selling out during the quarter.
Walleye Trading sold 10 Evoke Pharma shares in Q1 2016, an estimated $5K.
Walleye Trading first reported a position in Evoke Pharma in Q4 2015 and held it in 1 quarter.
Walleye Trading's Evoke Pharma position peaked at $5K in Q4 2015.
11 funds tracked by Wall St. Rank held Evoke Pharma as of Q1 2016.

Based on Walleye Trading's 13F filing for Q1 2016, filed 16 May 2016.